Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization

Vaccine effectiveness is lower and wanes faster against infection and symptomatic disease caused by the omicron variant of SARS-CoV-2 than was observed with previous variants. Vaccine effectiveness against severe omicron disease, on average, is higher, but has shown variability, including rapid appa...

Descripción completa

Detalles Bibliográficos
Autores principales: Feikin, Daniel R., Abu-Raddad, Laith J., Andrews, Nick, Davies, Mary-Ann, Higdon, Melissa M., Orenstein, Walter A., Patel, Minal K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058052/
https://www.ncbi.nlm.nih.gov/pubmed/35595662
http://dx.doi.org/10.1016/j.vaccine.2022.04.069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058052/
https://www.ncbi.nlm.nih.gov/pubmed/35595662
http://dx.doi.org/10.1016/j.vaccine.2022.04.069

Ejemplares similares